On the Consequences of Cell Fusion in COVID-19 Patients

Yuri Lazebnik

doi:10.20944/preprints202106.0125.v1

Submitted:

02 June 2021

Posted:

04 June 2021

Read the latest preprint version here

Part of the Following Collection

Preprints on COVID-19 and SARS-CoV-2

Subscription

Notify me about updates to this article or when a peer-reviewed version is published.

Preprint

Hypothesis

This version is not peer-reviewed.

On the Consequences of Cell Fusion in COVID-19 Patients

Yuri Lazebnik^*

A peer-reviewed version of this preprint was published in:

Oncotarget 2021, 12(25), 2476-2488. https://doi.org/10.18632/oncotarget.28088

Submitted:

02 June 2021

Posted:

04 June 2021

Read the latest preprint version here

Part of the Following Collection

Preprints on COVID-19 and SARS-CoV-2

Abstract

This commentary proposes how the coronavirus SARS- CoV-2 can contribute to clinical manifestations of COVID-19 by producing syncytia.

Keywords:

cell fusion

;

syncytia

;

hybrids

;

viruses

;

coronaviruses

;

SARS-CoV-2

;

COVID-19

;

blood coagulation cascade

;

thrombosis

;

cancer

Subject:

Biology and Life Sciences - Virology

Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.